Schneider National Inc
For the period ended Dec 31, 2023. Filed Feb 23, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 23, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Investments
- INVESTMENTS
Marketable Securities
The following table presents the maturities and values of our marketable securities as of the dates shown.
| December 31, 2023 · December 31, 2022 | |||||
|---|---|---|---|---|---|
| (in millions, except maturities in months) | Maturities | Amortized Cost | Fair Value | Amortized Cost | Fair Value |
| U.S. treasury and government agencies | 8 to 86 | $24.9 | $22.9 | $21.9 | $19.3 |
| Corporate debt securities | 4 to 112 | 20.0 | 19.2 | 16.0 | 14.9 |
| State and municipal bonds | 6 to 178 | 15.5 | 15.1 | 12.4 | 11.7 |
| Total marketable securities | $60.4 | $57.2 | $50.3 | $45.9 | |
Equity Investments without Readily Determinable Fair Values
The Company’s primary strategic equity investments without readily determinable fair values include Platform Science, Inc., a provider of telematics and fleet management tools; MLSI, a transportation technology development company and ChemDirect, a business to business digital marketplace for the chemical industry. These investments are being accounted for under ASC 321, Investments - Equity Securities, using the measurement alternative, and their combined values as of December 31, 2023 and 2022 were $121.8 million and $86.0 million, respectively. If the Company identifies observable price changes for identical or similar securities of the same issuer, the equity security is measured at fair value as of the date the observable transaction occurred using Level 3 inputs. In addition to our investment in MLSI, we also hold a $10.0 million note receivable from MLSI as of December 31, 2023. The note was funded during the first quarter of 2023, is subject to interest over its term, and matures in March 2030.
The following table summarizes the activity related to these equity investments during the periods presented.
| Year Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2023 | 2022 | 2021 |
| Investment in equity securities | $15.8 | $24.0 | $— |
| Upward adjustments (1) | 20.0 | 25.8 | 13.9 |
| Cumulative upward adjustments | 72.0 | ||
(1)Our updated investment values were determined using the backsolve method, a valuation approach that primarily uses an option pricing model to value shares based on the price paid for recently issued shares.
Equity Investments with Readily Determinable Fair Values
Our non-controlling interest in TuSimple is accounted for under ASC 321, Investments - Equity Securities. In the years ended December 31, 2023 and 2022, the Company recognized pre-tax net losses of $0.3 million and $12.1 million, respectively, on its investment in TuSimple. See Note 4, Fair Value, for additional information on the fair value of our investment in TuSimple.
Equity Method Investment
In the second quarter of 2023, the Company invested $5.0 million consisting primarily of internal use software and cash in exchange for a 50% non-controlling ownership interest in Scope 23 LLC, an entity that provides a platform for shippers to track and manage their greenhouse gas emissions. Our interest is being accounted for under ASC 323, Investments - Equity Method and Joint Ventures. For the year ended December 31, 2023, we recorded losses in the amount of $0.1 million related to our investment, and the carrying value of our investment was $4.9 million as of December 31, 2023.
All of our equity investments, as well as our note receivable from MLSI, are included in internal use software and other noncurrent assets on the consolidated balance sheets. Gains or losses on our equity investments are recognized within other expenses (income)—net on the consolidated statements of comprehensive income.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.